Krill Oil

The Verdict

Krill oil delivers the same omega-3 as fish oil at three to five times the price, with no proven clinical advantage at matched dose.

Krill oil is the oil pressed from Antarctic krill — tiny shrimp-like crustaceans the size of paperclip. People take it for the same reason they take fish oil: to get EPA and DHA, the two omega-3 fatty acids your body cannot make in useful amounts. The pitch is that krill carries its EPA and DHA on phospholipids instead of plain triglycerides, so your body grabs them faster. Think of it like two delivery trucks dropping off the same package. The trucks look different. The package is identical. By the time you check the doorstep four weeks later, the package is sitting there either way.

The verdict: Krill works for raising your omega-3 level the same way fish oil works, and at matched dose the rise is identical. The 2023 head-to-head trial that compared the two for 12 weeks settled this question.
What most people get wrong: A 500 mg krill capsule is not the same as a 500 mg fish oil capsule. The krill capsule typically contains half the EPA and DHA. You are paying triple the price for less of the active ingredient.
Start here: Take 2 to 4 grams a day total oil providing 200 to 600 mg of EPA plus DHA with a fat-containing meal. Whichever source has the lowest cost per milligram of EPA plus DHA — usually a standard fish oil at around £1.50 per week.

Best for

Adults with low omega-3 levels who prefer the burp tolerance of phospholipid forms and don't mind paying the premium. Older adults trialing it for muscle function under clinical supervision.

Skip if

You are allergic to shellfish (krill is a crustacean). You have very high triglycerides above 500 mg/dL and need prescription EPA. You are choosing krill purely on the bioavailability story — buy fish oil and save 60 to 80 percent.

Want the full evidence? Keep scrolling

The Protocol

Population	Dose	Form	Timing
General adult repletion (omega-3 index under 4 percent)	2 g/d providing ~200 mg EPA+DHA	Whichever source is cheapest per mg EPA+DHA — usually fish oil	With a fat-containing meal
Hypertriglyceridemia 150–500 mg/dL	2–4 g/d providing 200–600 mg EPA+DHA	Krill or matched-dose fish oil (equivalent effect)	With a meal
Severe hypertriglyceridemia ≥500 mg/dL	4 g/d prescription icosapent ethyl	NOT krill — failed primary endpoint (Mozaffarian 2022)	With a meal
Knee osteoarthritis	Evidence does not support routine use	Standard joint protocol takes priority	—
Older adults ≥65y, sarcopenia adjunct	4 g/d	Krill oil	With a meal
Dry eye disease	1–2 g/d providing ~900 mg EPA + 500 mg DHA	Krill or matched-dose fish oil	With a meal
Pregnancy / lactation	Defer to algal DHA or fish oil	Krill-specific prenatal data insufficient	With a meal
Major depressive disorder adjunct	EPA-dominant fish oil — krill not superior	Fish oil ≥60% EPA	With a meal

Forms Comparison

Standard fish oil (TG)

Reference standard

Equal omega-3 rise to krill at matched EPA+DHA dose. The default value choice.

£6–15/month

Krill oil (Superba2 / NKO)

Phospholipid 30–60%

Burp tolerance, smaller capsule, bundled astaxanthin (sub-therapeutic dose).

£30–60/month

rTG fish oil

Re-esterified triglyceride

Slightly higher acute absorption than ethyl ester; equal at steady state.

£15–25/month

Ethyl ester fish oil

EE — generic

Cheapest. Take with food. Adequate at steady state for general use.

£5–10/month

Algal DHA

Vegetarian TG

Vegetarians, vegans, pregnancy. DHA-dominant.

£20–40/month

Icosapent ethyl (Rx)

Prescription EPA

Severe HTG, high-risk CVD. Regulatory grade.

Prescription

Absorption Tips

Take with a fat-containing meal. The phospholipid form is less dependent on dietary fat than ethyl-ester fish oil, but food helps both. Refrigerate the bottle after opening and keep out of direct light — astaxanthin in krill is partly protective against oxidation but does not overcome real supply-chain abuse. Look for IFOS, USP, or NSF third-party certification. If the bottle smells fishy or rancid on opening, return it. Do not split into more than two doses per day.

Safety & Interactions

Crustacean shellfish allergy — Severe

Krill is a crustacean. Allergen cross-reactivity with shrimp tropomyosin is clinically documented. Avoid entirely. Use fish oil or algal DHA instead.

Warfarin and DOACs — Moderate

Theoretical bleeding-time prolongation at higher EPA+DHA doses. Monitor INR at krill doses ≥3 g/d. Clinician supervision required.

Severe hypertriglyceridemia ≥500 mg/dL — Wrong indication

Krill oil 4 g/d × 26 weeks was NULL on primary endpoint vs olive oil placebo in the regulatory-grade Mozaffarian 2022 trial. Use prescription icosapent ethyl. Krill is not a substitute.

Antiplatelet agents (aspirin, clopidogrel) — Mild

Additive antiplatelet effect. Usually clinically minor at standard doses. Case-level concern at high doses.

Pregnancy and lactation — Insufficient data

Krill-specific prenatal data are insufficient. Defer to algal DHA or fish oil for the prenatal indication — both have the evidence base.

Side Effects

Mild GI upset (loose stool, nausea) in 3–8% at 2–4 g/d. Fishy aftertaste or burp in 5–15%, often less than ethyl-ester fish oil at matched dose. Allergic reaction is rare but reportable in shellfish-sensitized individuals.

Upper Limit

EFSA 2012 Scientific Opinion: supplemental EPA+DHA combined ≤5 g/d in healthy adults. No krill-specific UL set.

Conviction

MODERATE — endpoint-stratified

Omega-3 index repletion: HIGH. Triglyceride lowering 150–500 mg/dL: MODERATE. Severe HTG ≥500 mg/dL: DEBUNKED (Mozaffarian 2022 NULL primary). Knee osteoarthritis: LOW (Laslett 2024 JAMA NULL primary). Premium-form superiority over fish oil at matched EPA+DHA: NONE. Cognition in healthy adults: LOW. Muscle function ≥65y: EMERGING.

What would change this

A pre-registered, independent (non-industry-funded), double-blind RCT enrolling 400–600 adults with mild-to-moderate knee OA, randomizing 1:1:1 to krill oil 4 g/d, EPA+DHA-matched fish oil 4 g/d, and olive oil placebo, with WOMAC pain at 24 weeks as the primary endpoint. If krill significantly outperforms BOTH placebo AND matched-dose fish oil with a between-group difference at or above the minimum clinically important difference of 2 points, the OA conviction upgrades. Without an active comparator at matched EPA+DHA dose, no future trial can resolve the krill-vs-fish-oil question.

Sources

Laslett LL, et al. (2024). Krill Oil for Knee Osteoarthritis: A Randomized Clinical Trial (KARAOKE). JAMA. PMID 38776073. N=262 — NULL primary at 4 g/d × 24 weeks.
Stonehouse W, et al. (2022). Krill oil improved osteoarthritic knee pain in mild-to-moderate knee OA: 6-month multicenter RCT. Am J Clin Nutr. PMID 35880828. N=235 — WOMAC −1.4 vs placebo, below MCID. Aker BioMarine product supply.
Mozaffarian D, et al. (2022). Effectiveness of a Novel ω-3 Krill Oil Agent (CaPre) in Severe Hypertriglyceridemia. JAMA Network Open. PMID 34989797. N=520 — NULL primary at 4 g/d × 26 weeks. Acasti-funded.
Vosskötter F, et al. (2023). Equal bioavailability of omega-3 PUFA from Calanus oil, fish oil and krill oil: 12-week parallel study. Lipids. PMID 36960737. N=121 — definitive null on form-superiority.
Ursoniu S, et al. (2017). Lipid-modifying effects of krill oil: SR + MA of RCTs. Nutrition Reviews. PMID 28371906. 7 RCTs N=662.
Huang H, et al. (2023). Clinical effectiveness of krill oil on cardiovascular health: updated SR + MA. Diabetes Metab Syndr. PMID 38039646. 13 RCTs.
Kim MG, et al. (2020). Lipid-modifying effects of krill oil vs fish oil: network meta-analysis. Nutrition Reviews. PMID 32073633. No krill superiority at matched dose.
Pimentel T, et al. (2024). Krill oil for knee pain: SR + MA + TSA. Inflammopharmacology. PMID 39126570. SMD −0.37; TSA shows insufficient cumulative N.
Alkhedhairi SA, et al. (2022). Krill oil supplementation on skeletal muscle in older adults. Clin Nutr. PMID 35504165. N=94 — strength + thigh volume improved.
Deinema LA, et al. (2017). Two Forms of Omega-3 for Dry Eye Disease. Ophthalmology. PMID 27817918. N=54 — krill and fish oil both improved OSDI.
Açik M, et al. (2025). Fish oil vs krill oil in MDD. J Affect Disord. PMID 40118278. N=84 — no krill superiority.
Ramprasath VR, et al. (2013). Enhanced increase of omega-3 index from krill oil vs fish oil. Lipids Health Dis. PMID 24304605. Foundational bioavailability paper — dose-asymmetry critique applies.
EFSA Panel (2012). Scientific Opinion on Tolerable Upper Intake Level of EPA, DHA, DPA. EFSA Journal. [cite-unverified] Regulatory anchor.

Action ROI

Is this worth your time, money, effort, risk, and trust for this goal? Different from Verdict Score (evidence strength) and Leverage Map (relative importance) — Action ROI is the worth-it call once friction is priced in.

Action ROI score

58/100 Situational ROI Trust grade B

Conditional - omega-3 itself is worth it, but krill is the wrong way to buy it for most people because fish oil does the same job for a fraction of the price.

Time

Low

Money

Medium

Effort

Low

Risk

Medium

Why this score

The core mechanism works but is not krill-specific: at matched EPA+DHA dose krill raises the omega-3 index exactly as much as cheaper fish oil (Vosskotter 2023, PMID 36960737, N=121, 12 weeks), so the benefit is real and the premium carrier adds nothing.
Triglyceride lowering is genuine but modest and shared with fish oil: the updated meta-analysis (Huang 2023, PMID 38039646, 13 RCTs) shows TG drops while LDL and HbA1c are not significant - and the joint claim this buyer often wants is essentially dead, with the largest knee OA trial null (Laslett 2024, JAMA, N=262) and the positive one below the clinical threshold (Stonehouse 2022).
Money is the deciding dimension: about $38 to $75 a month for krill versus roughly $8 to $19 for dose-matched fish oil, so you pay 3 to 5x per gram of EPA+DHA for no demonstrated outcome edge.
Trust grade is B: the omega-3 repletion and TG evidence is strong, but krill-specific superiority is debunked, and the severe-hypertriglyceridemia trial was null versus placebo (Mozaffarian 2022, JAMA Open, N=520), so krill does not replace prescription EPA.
Risk is Medium, not Low: krill is a crustacean and is contraindicated in shellfish allergy, and at 3 g/day or more it can prolong bleeding time, so anticoagulant users need INR monitoring - that caps the band.

Why it didn’t score higher

The whole reason this buyer chose krill - superior absorption - is a dose-matching artifact that vanishes at steady state, so the premium buys nothing.
The joint-health half of the goal is unsupported: the largest, most rigorous knee trial was null and the positive one fell below the minimum clinically important difference.
Shellfish-allergy contraindication plus a bleeding-time interaction at higher doses keep risk at Medium, which caps the score below the High band.

Best for

Adults with a documented low omega-3 index (<4 to 5%) who specifically prefer krill's smaller capsule or better burp tolerance and accept the price
Adults with hypertriglyceridemia 150 to 500 mg/dL seeking a modest 10 to 20% TG reduction (where dose-matched fish oil works equally)
People without a shellfish allergy who tolerate krill better than ethyl-ester fish oil

Lower ROI if

You chose krill purely for bioavailability - the advantage is gone at matched EPA+DHA dose, so buy fish oil and save 60 to 80%
You are buying it for knee or joint pain - the largest trial was null and the positive one was below the clinical threshold
You have severe hypertriglyceridemia at or above 500 mg/dL - use prescription icosapent ethyl, since krill failed its regulatory-grade trial
You have a crustacean shellfish allergy, or you are buying it as a meaningful astaxanthin or choline source (the bundled doses are too small)

Minimum effective dose

2 to 4 g/day of total oil providing 200 to 600 mg EPA+DHA, with a fat-containing meal, matched by the EPA+DHA on the label rather than capsule weight. For the same effect, dose-matched standard fish oil works at roughly one-third the cost. There is no krill-specific dose advantage.

Track this

Omega-3 index before and after - test first, because if you are already above 8% supplementation is not fixing anything
Fasting triglycerides at baseline and 8 to 12 weeks if that is your indication
The EPA+DHA figure on the label versus a fish oil alternative at the same daily cost (krill usually loses on cost per gram)

Krill oil delivers the same EPA and DHA as fish oil at 3-5x the price, with no proven advantage at matched dose.

Best for

Skip if

The Protocol

Forms Comparison

Absorption Tips

Safety & Interactions

Crustacean shellfish allergy — Severe

Warfarin and DOACs — Moderate

Severe hypertriglyceridemia ≥500 mg/dL — Wrong indication

Antiplatelet agents (aspirin, clopidogrel) — Mild

Pregnancy and lactation — Insufficient data

Side Effects

Upper Limit

Conviction

Worth Your Money?

Sources

Action ROI

Get the complete dosing protocol

Related free research

There are 424 more inside